LUCID DIAGNOSTICS
Lucid Diagnostics Inc. is a commercial-stage, cancer prevention medical diagnostics company. Lucid is focused on the millions of patients with gastroesophageal disease (GERD), also known as chronic heartburn, who are at risk of developing esophageal precancer and cancer. Lucid’s EsoGuard® Esophageal DNA Test, performed on samples collected in a brief noninvasive office procedure with its EsoCheck® Esophageal Cell Collection Device, is the first and only commercially available diagnostic test capable of serving as a widespread screening tool to prevent cancer and cancer deaths through early detection of esophageal precancer in at-risk GERD patients.
LUCID DIAGNOSTICS
Industry:
Health Care Health Diagnostics Therapeutics
Founded:
2018-05-30
Status:
Active
Contact:
2129494319
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible LetsEncrypt Apple Mobile Web Clips Icon Content Delivery Network Apache Euro Amazon GStatic Google Static Content COVID-19
Similar Organizations
Advanced Cell Diagnostics
Advanced Cell Diagnostics is a molecular pathology company developing cell- and tissue-based diagnostic tests for personalized medicine.
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-10-07 | CapNostics | CapNostics acquired by Lucid Diagnostics | N/A |
Key Employee Changes
| Date | New article |
|---|---|
| 2021-10-21 | Lucid Diagnostics Appoints Suman Verma MD, PhD as Chief Scientific Officer |
More informations about "Lucid Diagnostics"
Who we are - LucidDX
At Lucid Diagnostics, we believe early detection will make esophageal cancer a disease of the past. We're using targeted next generation sequencing to fundamentally change the way esophageal precancer is detected. Join a …See details»
LUCID DIAGNOSTICS INC. - Crunchbase Company Profile & Funding
Lucid Diagnostics is a commercial-stage, cancer-prevention medical diagnostics company. Lucid focuses on patients with gastroesophageal disease (GERD), also known as chronic heartburn, …See details»
Lucid Diagnostics
Lucid Diagnostics Corporate Headquarters 360 Madison Ave, Floor 25 New York, NY 10017 Lucid Dx Labs 14 Orchard Road Lake Forest, CA 92630 Email [email protected]See details»
Lucid Diagnostics Launches New Corporate Website
Jul 11, 2024 About Lucid Diagnostics Lucid Diagnostics Inc. is a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq: PAVM). Lucid is focused on the millions of patients …See details»
Leadership [CMS]
Lucid Diagnostics Corporate Headquarters 360 Madison Ave, Floor 25 New York, NY 10017. Lucid Dx Labs 14 Orchard Road Lake Forest, CA 92630. Email [email protected]. Phone …See details»
Lucid Diagnostic Investor Relations - Overview
Oct 15, 2021 Lucid Diagnostics Corporate Headquarters 360 Madison Ave, Floor 25 New York, NY 10017. Lucid Dx Labs 14 Orchard Road Lake Forest, CA 92630. Email …See details»
Lucid Diagnostics Launches New Corporate Website - Yahoo Finance
Jul 11, 2024 Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company, and majority-owned subsidiary of …See details»
Lucid Diagnostics Inc. (LUCD) Company Profile & Overview - Stock …
Oct 14, 2021 Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company in the United States. The company focuses on patients with …See details»
Lucid Diagnostics Provides Business Update and Second Quarter …
NEW YORK, Aug. 12, 2024 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company") a commercial-stage, cancer prevention medical diagnostics company, and …See details»
Lucid Diagnostics - businessabc
4 days ago Lucid Diagnostics was founded in 2021 as a spin-off of Code Engineering, Inc., a world-leading provider of medical imaging systems. Since then, we have rapidly developed …See details»
Lucid Diagnostics Company Profile - Office Locations ... - Craft
Oct 29, 2024 Lucid Diagnostics $2.4 m in annual revenue in FY 2023. See insights on Lucid Diagnostics including office locations, competitors, revenue, financials, executives, …See details»
Lucid Diagnostics - Org Chart, Teams, Culture & Jobs - The Org
View Lucid Diagnostics' up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
Lucid Diagnostics Chairman & CEO, Dr. Lishan Aklog, Highlights …
Feb 15, 2024 Lucid Diagnostics Chairman & CEO, Dr. Lishan Aklog, Highlights EsoCheck® Esophageal Cell Collection Device during Congressional Testimony PR Newswire Thu, Feb …See details»
Lucid Diagnostics - Overview, News & Similar companies - ZoomInfo
May 13, 2024 Lucid Diagnostics is a highly differentiated, medical device innovator with products designed to diagnose and treat conditions of the esophagus, in cluding conditions arising from …See details»
Lucid Diagnostics Expands Direct Contracting Initiative with …
NEW YORK, Nov. 5, 2024 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company, and …See details»
Lucid Diagnostics' ESOGUARD BE-1 Prospective Multicenter …
Nov 7, 2024 Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company") a commercial-stage, cancer prevention medical diagnostics company and subsidiary of PAVmed Inc. …See details»
Careers - LucidDX
At Lucid Diagnostics, we believe early detection will make esophageal cancer a disease of the past. ... We uphold human rights standards and promote diversity, equity, and inclusion across …See details»
Lucid Diagnostic Investor Relations - Board of Directors
Ronald M. Sparks. Director. Ronald M. Sparks has served as a member of PAVmed’s board of directors since January 2015. Mr. Sparks has more than 42 years of executive experience in …See details»
Lucid Diagnostics Partners with VITALExam to Enhance Esophageal ...
Dec 19, 2024 Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company and subsidiary of PAVmed Inc. …See details»
Lucid Medical Diagnostics - Company Profile - Tracxn
Dec 24, 2024 Lucid Medical Diagnostics - Chain of radiology & pathology laboratory centers. Raised a total funding of $1.53M over 3 rounds from 20 investors. Valued at $3.39M. Lucid …See details»